Katharina Brusniak

Katharina Brusniak

Auto-generated profile, based on publicly available information

Katharina Brusniak

Department of Anesthesiology and Intensive Care Unit, Florence-Nightingale-Hospital, Duesseldorf, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
KBKatharina Brusniak
Katharina Brusniak
HAHannah Maria Arndt
Hannah Maria Arndt
MFManuel Feisst
Manuel Feisst
KHKathrin Hassdenteufel
Kathrin Hassdenteufel
LMLina Maria Matthies
Lina Maria Matthies
SWStephanie Wallwiener
Stephanie Wallwiener
Background: Pregnant women are increasingly using mobile apps to access health information during the antenatal period. Therefore, digital health solutions can potentially be used as monitoring instruments during pregnancy. However, a main factor of success is high user engagement. Objective: The aim of this study was to analyze engagement and factors influencing compliance in a longitudinal study targeting pregnant women using a digital health app with self-tracking. Methods: Digitally collected data concerning demographics, medical history, technical aspects, and mental health from 585 pregnant women were analyzed. Patients filling out ≥80% of items at every study visit were considered to be highly compliant. Factors associated with high compliance were identified using logistic regression. The effect of a change in mental and physical well-being on compliance was assessed using a one-sample t test. Results: Only 25% of patients could be considered compliant. Overall, 63% left at least one visit blank. Influential variables for higher engagement included higher education, higher income, private health insurance, nonsmoking, and German origin. There was no relationship between a change in the number of physical complaints or depressive symptoms and study dropout. Conclusions: Maintaining high engagement with digital monitoring devices over a long time remains challenging. As cultural and socioeconomic background factors had the strongest influence, more effort needs to be directed toward understanding the needs of patients from different demographic backgrounds to ensure high-quality care for all patients. More studies need to report on compliance to disclose potential demographic bias.

8 February 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DGDr. Joachim Graf
Dr. Joachim Graf
NSNina Sickenberger
Nina Sickenberger
KBKatharina Brusniak
Katharina Brusniak
LMLina Maria Matthies
Lina Maria Matthies
TDThomas M Deutsch
Thomas M Deutsch
MWMarkus Wallwiener
Markus Wallwiener
Background: One in eight women is diagnosed with breast cancer in the course of their life. As systematic palliative treatment has only a limited effect on survival rates, the concept of health-related quality of life (HRQoL) was developed for measurement of patient-centered outcomes. Various studies have already demonstrated the reliability of paper-based patient-reported outcome (pPRO) and electronic patient-reported outcome (ePRO) surveys and that the 2 means of assessment are equally valid. Objective: The aim of this study was to analyze the acceptance and evaluation of a tablet-based ePRO app for breast cancer patients and to examine its suitability, effort, and difficulty in the context of HRQoL and sociodemographic factors. Methods: Overall, 106 women with adjuvant or advanced breast cancer were included in a 2-center study at 2 major university hospitals in Germany. Patients were asked to answer HRQoL and PRO questionnaires both on a tablet on-site using a specific eHealth assessment website and on paper. The suitability, effort, and difficulty of the app and self-reported technical skills were also assessed. Only the results of the electronically acquired data are presented here. The results of the reliability of the pPRO data have already been published elsewhere. Results: Patients regarded the ePRO assessment as more suitable (80/106, 75.5%), less stressful (73/106, 68.9%), and less difficult (69/106, 65.1%) than pPRO. The majority of patients stated that ePRO assessment improves health care in hospitals (87/106, 82.1%). However, evaluation of ePROs depended on the level of education (P=.003) in the dimensions of effort and difficulty (regression analysis). The app was rated highly in all categories. HRQoL data and therapy setting did not show significant correlations with the app’s evaluation parameters. Conclusions: The results indicate that ePRO surveys are feasible for measuring HRQoL in breast cancer patients and that those patients prefer ePRO assessment to pPRO assessment. It can also be seen that patients consider ePRO assessment to improve hospital health care. However, studies with larger numbers of patients are needed to develop apps that address the needs of patients with lower levels of education and technical skills.

29 April 2023 in European Journal of Cancer
Verified
Journal Article
Closed access
TDThomas M. Deutsch
Thomas M. Deutsch
APAndré Pfob
André Pfob
KBKatharina Brusniak
Katharina Brusniak
Fabian RiedelFabian Riedel
Fabian Riedel
ABArmin Bauer
Armin Bauer
MWMarkus Wallwiener
Markus Wallwiener

12 October 2021 in JMIR Cancer
Verified
Journal Article
Open access
KBKatharina Brusniak
Katharina Brusniak
MFManuel Feisst
Manuel Feisst
LSLinda Sebesteny
Linda Sebesteny
AHAndreas Hartkopf
Andreas Hartkopf
DGDr. Joachim Graf
Dr. Joachim Graf
TDThomas M Deutsch
Thomas M Deutsch
Background: Health-related quality of life (HRQoL) is used to evaluate the treatment of metastatic breast cancer. In a long-term therapy setting, HRQoL can be used as an important benchmark for treatment success. With the help of digital apps, HRQoL monitoring can be extended to more remote areas and be administered on a more frequent basis. Objective: This study aims to evaluate 3 common HRQoL questionnaires in metastasized breast cancer in terms of TTD in a digital, web-based setting. We further aim to examine the development of the HRQoL in different systemic treatment groups in each of these evaluation instruments. Methods: A total of 192 patients with metastatic breast cancer were analyzed in this bicentric prospective online cohort study at two German university hospitals. Patients completed questionnaires on HRQoL (EuroQol Visual Analog Scale [EQ-VAS], EuroQol 5 Dimension 5 Level [EQ-5D-5L], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30 item [EORTC QLQ-C30]) via an online platform over a 6-month period. Treatment schedules and medical history were retrieved from medical records. Unadjusted Cox regression analysis on treatment-related factors was performed. We conducted subgroup analyses in regard to TTD events between different treatments. Results: The EQ-VAS showed a higher rate of deterioration after 8 weeks (84/179, 46.9%) than the EQ-5D-5L (47/163, 28.8%) and EORTC QLQ-C30 (65/176, 36.9%). Unadjusted Cox regression revealed significant connections between known metastases in the liver (P=.03, HR 1.64, 95% CI 1.06-2.52) and pleura (P=.04, HR 0.42, 95% CI 0.18-0.96) in the EQ-VAS. Significant relations between EQ-VAS events and single EQ-5D-5L items and the EQ-5D-5L summary score were demonstrated. All treatment groups significantly differed from the CDK4/6 inhibition subgroup in the EQ-VAS. Conclusions: Compared to the EQ-5D-5L and QLQ-C30, the EQ-VAS showed a higher rate of deterioration after 8 weeks. Significant connections to certain metastatic locations were only detected in the EQ-VAS. The EQ-VAS is capable of reflecting the distinctive HRQoL profiles of different systemic treatments as well as the different aspects of HRQoL presented in the EQ-5D-5L. TTD with the EQ-VAS is an adequate mean of examining longitudinal development of HRQoL among breast cancer patients.

10 December 2021 in JMIR Mental Health
Verified
Journal Article
Open access
KHKathrin Hassdenteufel
Kathrin Hassdenteufel
KLKatrin Lingenfelder
Katrin Lingenfelder
CSCornelia E Schwarze
Cornelia E Schwarze
MFManuel Feisst
Manuel Feisst
KBKatharina Brusniak
Katharina Brusniak
SWStephanie Wallwiener
Stephanie Wallwiener
Background: Postpartum depression (PPD) is a severe mental disorder that often results in poor maternal-infant attachment and negatively impacts infant development. Universal screening has recently been recommended to identify women at risk, but the optimal screening time during pregnancy has not been defined so far. Thus, web-based technologies with widespread use among women of childbearing age create new opportunities to detect pregnancies with a high risk for adverse mental health outcomes at an early stage. Objective: The aim of this study was to stratify the risk for PPD and to determine the optimal screening time during pregnancy by using a web-based screening tool collecting electronic patient-reported outcomes (ePROs) as the basis for a screening algorithm. Methods: In total, 214 women were repeatedly tested for depressive symptoms 5 times during and 3 times after pregnancy by using the Edinburgh Postnatal Depression Scale (EPDS), accessible on a web-based pregnancy platform, developed by the authors of this study. For each prenatal assessment, the area under the curve (AUC), sensitivity, specificity, and predictive values for PPD were calculated. Multivariate logistic regression analyses were applied to identify further potential predictors, such as age, education, parity, relationship quality, and anxiety, to increase predictive accuracy. Results: Digitally collected data from 214 pregnant women were analyzed. The predictive accuracy of depressive symptoms 3 and 6 months postpartum was reasonable to good regarding the screening in the second (AUC=0.85) and third (AUC=0.75) trimester. The multivariate logistic regression analyses resulted in an excellent AUC of 0.93 at 3 months and a good AUC of 0.87 at 6 months postpartum. Conclusions: The best predictive accuracy for PPD has been shown for screening between the 24th and the 28th gestational week (GW) and seems to be beneficial for identifying women at risk. In combination with the aforementioned predictive factors, the discriminatory power improved, particularly at 3 months postpartum. Screening for depression during pregnancy, combined with the women’s personal risk profile, can be used as a starting point for developing a digital screening algorithm. Thereby, web-based assessment tools constitute feasible, efficient, and cost-effective approaches. Thus, they seem to be beneficial in detecting high-risk pregnancies in order to improve maternal and infant birth outcomes in the long term.

12 June 2025 in JMIR Human Factors
Verified
Journal Article
Open access
KKKristina Killinger
Kristina Killinger
VSVerena Seyfried
Verena Seyfried
KBKatharina Brusniak
Katharina Brusniak
MWMarkus Wallwiener
Markus Wallwiener
MAMichael Abou-Dakn
Michael Abou-Dakn
SWStephanie Wallwiener
Stephanie Wallwiener
Background: The perinatal period is one of the most vulnerable times a woman experiences. Multidimensional, interprofessional, and personalized support is needed to improve outcomes in women’s and children’s health while strengthening partner relationships at the same time. Although a vast amount of support services already exist in Germany for psychosocial counseling during the perinatal period, groups who are especially at risk do not take advantage of them. Objective: Family eNav is an app-based intervention developed by experts in the field of medical and psychosocial support to help young parents navigate through primary and secondary care services in Germany according to their needs. It also empowers patient and parenting perspectives through self-education and symptom monitoring for different settings, for example, mental health and preterm birth. While the intervention will be evaluated in a multicenter, randomized, controlled trial, the focus here lies on the conception of the app, demand among patients, and preuse acceptance. Methods: During the conception phase, we conducted an explorative study with prospective users and experts in the perinatal psychosocial field to understand the need and preuse acceptance of the intervention. We interviewed 20 participants with a semistructured guide, analyzing their responses using systematic text condensation. Additionally, we conducted a short survey on general questions concerning digitalization within the health care system among the participants. Results: We established two main themes: (1) access and barriers to health care and psychosocial services and (2) high preuse acceptance of app-based intervention. Health care and psychosocial providers indicated that there is a high demand for their services, which cannot always be met immediately, and at the same time, they are doubtful of reaching those individuals most in need. Prospective users and health and social care providers alike showed great interest in the perinatal navigator and suggested a variety of needs and content requirements to be included. Regionality, availability, and individualized content were underlined as success factors for high user acceptance. Barriers consisted of data protection concerns, as well as denial of their own needs. Conclusions: Our findings show great acceptance for an app-based intervention on the part of both prospective users and service providers. Feedback on requirements and content, as well as possible barriers, was taken into consideration while developing the app.